Table 3.
Diagnostic group | (a) Main analysis | (b) Spatial dependence | (c) Instrumental variable analysis | ||||||||||
Unadjusted | Adjusted* | Unadjusted | Adjusted* | Unadjusted | Adjusted* | ||||||||
OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | ICC | OR | 95% CI | OR | 95% CI | |
Cardiovascular | 0.98 | 0.96 to 0.99 | 0.99 | 0.98 to 1.01 | 1.00 | 0.98 to 1.02 | 1.00 | 0.98 to 1.02 | 0.35 | 0.95 | 0.91 to 0.99 | 0.98 | 0.93 to 1.02 |
IHD | 1.01 | 0.99 to 1.03 | 1.01 | 0.99 to 1.04 | 0.99 | 0.96 to 1.02 | 0.99 | 0.96 to 1.02 | 0.28 | 0.95 | 0.88 to 1.02 | 0.95 | 0.88 to 1.03 |
Stroke | 0.95 | 0.89 to 1.00 | 1.00 | 0.97 to 1.04 | 1.00 | 0.96 to 1.04 | 1.02 | 0.98 to 1.07 | 0.14 | 0.92 | 0.83 to 1.02 | 0.99 | 0.88 to 1.10 |
Heart failure | 0.94 | 0.91 to 0.97 | 0.94 | 0.90 to 0.97 | 0.96 | 0.91 to 1.00 | 0.96 | 0.91 to 1.01 | 0.19 | 0.88 | 0.79 to 1.00 | 0.92 | 0.81 to 1.05 |
Respiratory | 0.97 | 0.96 to 0.98 | 0.97 | 0.96 to 0.99 | 1.00 | 0.99 to 1.02 | 1.00 | 0.98 to 1.02 | 0.37 | 0.98 | 0.95 to 1.02 | 1.00 | 0.95 to 1.05 |
COPD | 0.98 | 0.96 to 1.01 | 0.97 | 0.94 to 1.01 | 1.00 | 0.96 to 1.04 | 0.99 | 0.95 to 1.03 | 0.16 | 1.03 | 0.94 to 1.12 | 1.00 | 0.91 to 1.10 |
Asthma | 0.97 | 0.94 to 1.00 | 1.02 | 0.98 to 1.05 | 0.99 | 0.95 to 1.04 | 1.00 | 0.96 to 1.05 | 0.23 | 0.84 | 0.75 to 0.93 | 0.92 | 0.82 to 1.04 |
Bronchiolitis | 0.94 | 0.88 to 1.00 | 0.91 | 0.85 to 0.98 | 0.92 | 0.85 to 1.00 | 0.91 | 0.84 to 0.99 | 0.06 | 0.91 | 0.74 to 1.22 | 0.79 | 0.63 to 0.98 |
Adjusted for IMD in 2001, change in proportion of residents living in income deprivation between 2001 and 2005, change in population aged 65 years or older between 2001 and 2004,% non-white, % black (black Caribbean, black African, black other), % Asian (Indian, Pakistani, Bangladeshi, Asian other) and % Chinese residents.
COPD, chronic obstructive pulmonary disease; ICC, intraclass correlation; IHD, ischaemic heart disease; IMD, Index of Multiple Deprivation; NOx, oxides of nitrogen.